Fresenius Medical Care, the world’s largest provider of dialysis products and services, is still in the process of seeking approval by the U.S. Federal Trade Commission (FTC) for its acquisition of NxStage Medical, Inc. (“NxStage”) and therefore now expects the transaction to close in early 2019.
NxStage, which like Fresenius Medical Care North America is headquartered in the Boston, Massachusetts area, was founded in 1998 and has approximately 3,800 employees worldwide. In 2017, NxStage delivered USD 394 million in revenue.
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.
May 03, 2019
Ljubljana, Slovenia
EuroPD
European Society for Peritioneal Dialysis 3.5. - 5.5.2019
April 12, 2019
Melbourne, Australia
ISN
World Congress of Nephrology 12.4. - 15.4.2019
January 10, 2019
Vienna, Austria
EASL
Congress of the European Association for the Study of the Liver (EASL) 10.4. - 14.4.2019
January 14, 2019
New York, USA
Commerzbank German Investment Seminar
January 14 – 15, 2019
January 07, 2019
San Francisco, USA
37th Annual J.P. Morgan Healthcare Conference
January 7 – 8, 2019
March 19, 2019
Brussels, Belgium
ICU/ISICEM
Intensive Care and Emergency Medicine, Erasme University Hospital & Belgian Society of Intensive Care Medicine 19.3. - 22.3.2019
January 28, 2019
Dubai, UAE
Arab Health Congress
Arab Health Congress 28.1. - 31.1.2019
Fresenius has been awarded the HR Excellence Award 2018 in the Compensation & Benefits category for the global healthcare group’s compensatory time account calculator. This calculator enables employees to quickly and transparently access information on time off that they have banked, options to take leave for continuing education or to care for family members, and possible early retirement. The HR Excellence Awards have been presented by Human Resources Manager magazine since 2012 to recognize outstanding projects in personnel management.
Der Gesundheitskonzern Fresenius ist für seinen Langzeitkonto-Rechner mit dem „HR Excellence Award 2018“ in der Kategorie „Compensation & Benefits“ ausgezeichnet worden. Der Langzeitkonto-Rechner bietet den Mitarbeitern schnell und transparent Informationen über eingebrachte Beiträge, Auszeiten für die persönliche Weiterbildung oder die Pflege von Angehörigen sowie einen möglichen Vorruhestand. Mit den „HR Excellence Awards“ prämiert das Magazin „Human Resources Manager“ seit 2012 herausragende Projekte im Personalmanagement.